Gosset Ownership
Private
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Orion Biotechnology General Information
Orion Biotechnology is a clinical-stage biotech developing next-generation therapeutics targeting previously undruggable small protein GPCRs for obesity and metabolic disorders. The company leverages its proprietary PROcisionXTM platform to rapidly discover and develop peptide/protein-based drugs. It has a strong and diverse pipeline across development stages, though specific clinical results are not detailed in the available sources.
Contact Information
Primary Industry
Biotech
Corporate Office
Ottawa, Ontario
Canada
Canada
Drug Pipeline
No pipeline data available
Key Partnerships
Open to R&D collaborations and outlicensing opportunities centered around their PROcisionXTM platform; no specific partners named.
Orion Biotechnology Funding
No funding data available
To view Orion Biotechnology's complete valuation and funding history, request access »